期刊文献+

接种CEA重组痘苗病毒对小鼠CEA^+肿瘤抑制作用的机制探讨 被引量:3

A Study of the inhibitory effect of a recombinant CEA vaccinia virus inocnlation on mouse CE^A positive tumor
下载PDF
导出
摘要 目的探讨CEA重组痘苗病毒(rV-CEA)治疗CEA+肿瘤的机制。方法以我室构建的rV-CEA, 腹腔接种供体C57/BL小鼠,取其脾细胞及腹腔巨噬细胞(MΦ),分别过继转移给荷CEA+-HePa肝癌细胞的C57/BL小鼠,检测该供体小鼠脾细胞、腹腔MΦ及相应受体的脾细胞体外杀瘤细胞的效应。结果接种rV-CEA的供体小鼠的脾细胞及腹腔MΦ过继免疫给受体小鼠,具有明显抑制受体CEA阳性肿瘤生长的作用。体外实验表明,该供体脾细胞及接种了供体MΦ的受体脾细胞对同一靶细胞的杀伤活性明显增强,但供体MΦ体外的细胞毒活性无明显增加。结论rV-CEA对CEA+肿瘤的抑制作用,可能主要通过CEA特异性免疫反应激活T细胞而实现。MΦ作为抗原提呈细胞可通过激活T细胞而杀伤肿瘤细胞,具体机制值得进一步研究。 :Aim To explore antitumor mechanism of a recombinant vaccinia virus containing the human CEA-cDNA (rV-CEA). Methods C57/BL mice were immunized three times with rV-CEA. Six weeks later, the macrophages(MΦs)and splenocytes from rV-CEA-immunized donors were transferred to CEA+-HePa tnmor-bearing recipients,Meanwhile, the antitumor effects of these donor's MΦs and splenocytes and that of the recipient's splenocytes were detected in vitro. Results The MΦs and splenocytes from rV-CEA-immunized donors possessed strong antitumor activity in CEA-positive tumor-bearing recipients. The in vitro antitumor effect of splenocytes from mice inoculated with MΦs from rV-CEA-immunized donors were markedly stronger than those from W-VV-immunized donors. However,the in vitro antitumor effect of the MΦs from rV-CEA-immunized donors was the same as those from W-VV-immunized donors. Conclusion It is demonstrated that antitumor activity induced with rV-CEA may be mediated mainly by antigen present cells (the MΦs), which activated tumor-specific T cells to kill tumor cells.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2001年第4期324-327,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 广州市科委基金资助 No. JB02-98-5-018-01 广东省卫生厅资助课题 No.A1998127 广州医学院资助课题 No.2000-GK-14
关键词 癌胚抗原 重组痘苗病毒 免疫细胞 CEA阳性肿瘤 肿瘤抑制作用 carcinoembryonic antigen recombinant vaccinia virus immune cells CEA positive tumor antitumor effect
  • 相关文献

参考文献8

二级参考文献12

共引文献46

同被引文献18

  • 1方福德 周吕 等.现代医学实验技巧全书[M].北京:北京医科大学中国协和医科大学联合出版社,1999..
  • 2方福德,周吕,丁濂,等.现代医学实验技巧全书,第一版[M].北京医科大学中国协和医科大学联合出版社,1999.
  • 3Tang KC,Hosi J,Grabble S. Epidermal cells presentation of tumor associated anigen for the induction of tolerance[J]. J Immunol,1994,152:3410.
  • 4June CH,Bluestone JA,Nadler LM,et al.The B7 and CD28 receptor famillies[J]. Immunol today,1994,15(7):321.
  • 5Hodge JW,McLaughlin JP,Abrams SI,et al. Admixture of a recombinant vaccinia virus containing the gene for the costimulatory molecule B7 and a recombinant vaccinia virus containing a tumor-associated antigen gene results in enhanced specific T-cell responses and antitumor immunity. [J]. Cancer Res,1995 Aug 15;55(16): 3598-603.
  • 6Lorenz MG,Kantor JA,Schlom J,et al. Anti-tumor immunity elicited by a recombinant vaccinia virus expressing CD70(CD27L)[J]. Hum Gene Ther,1999,10(7):1095.
  • 7Sensi M and Parmiani G. Analysis of TCR usage in human tumors[J]: a new tool for assessing tumor-specific immune responses Immunol Today,1995,16(12):588.
  • 8Grabbe S,Beissert S,Schwarz T,et al.Dendritic cells as initiators of tumor immune response: a possible stradegy for tumor immunotherapy [J].Immunol Today,1995,16(11):547.
  • 9Dranoff C,Jaffee E,Vaccination with irradiated tumor cells engineered to secrete murine GM-CSF stimulates potent specific and long lasting antitumor immunity[J].Proc Natl Acad Sci USA,1993,90:3539.
  • 10方福德,周吕,丁濂,等.现代医学实验技巧全书[M].第一版,北京医科大学中国协和医科大学联合出版社,1999.

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部